|
DDOST expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.38999939231144E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17200002428086E-09 |
| Normal-vs-Stage2 |
1.703080E-03 |
| Normal-vs-Stage3 |
6.5936145432488E-13 |
| Normal-vs-Stage4 |
1.01999519941387E-11 |
| Stage1-vs-Stage2 |
1.265160E-01 |
| Stage1-vs-Stage3 |
9.355000E-03 |
| Stage1-vs-Stage4 |
8.563400E-03 |
| Stage2-vs-Stage3 |
2.276700E-03 |
| Stage2-vs-Stage4 |
2.040800E-03 |
| Stage3-vs-Stage4 |
5.322400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.9508617771512E-12 |
| Normal-vs-AfricanAmerican |
1.117430E-03 |
| Normal-vs-Asian |
1.18910437052477E-11 |
| Caucasian-vs-AfricanAmerican |
9.993800E-01 |
| Caucasian-vs-Asian |
3.714600E-01 |
| AfricanAmerican-vs-Asian |
7.310000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.59329999088942E-09 |
| Normal-vs-Female |
6.85770329411639E-11 |
| Male-vs-Female |
9.329800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.28139951374828E-10 |
| Normal-vs-Age(41-60Yrs) |
4.87160312090396E-11 |
| Normal-vs-Age(61-80Yrs) |
8.12099998359628E-09 |
| Normal-vs-Age(81-100Yrs) |
1.072470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.415200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.557800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.047800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.660600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.349200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.245400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.86080000297295E-08 |
| Classical-VS-Follicular |
5.455500E-03 |
| Classical-VS-Other |
5.030400E-01 |
| Classical-VS-Normal |
3.43813866265918E-12 |
| Tall-VS-Follicular |
3.43679973369149E-10 |
| Tall-VS-Other |
2.473400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.730570E-01 |
| Follicular-VS-Normal |
1.079180E-03 |
| Other-VS-Normal |
4.223500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.27579999792604E-08 |
| Normal-vs-N1 |
3.6235014988506E-11 |
| N0-vs-N1 |
2.981500E-03 |
|
|
